Is HBF 386 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use HBF 386? Is HBF 386 safe for nursing mother and child? Does HBF 386 extracts into breast milk? Does HBF 386 has any long term or short term side effects on infants? Can HBF 386 influence milk supply or can HBF 386 decrease milk supply in lactating mothers?
HBF 386 lactation summary
- DrLact safety Score for HBF 386 is 7 out of 8 which is considered Dangerous as per our analyses.
- A safety Score of 7 indicates that usage of HBF 386 may cause toxic or severe side effects in breastfed baby.
- Our study of different scientific research indicates that HBF 386 may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using HBF 386 .
- Usage of HBF 386 is in contradiction to breastfeeding hence if it is must to use HBF 386 and there is no better alternative available then breastfeeding shall be stopped permanently or temporarily.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About HBF 386 usage in lactation
Drug is cleared from the body in 7 elimination half-lives. Resuming breastfeeding is likely safe after 10 days of pumping-and-dumping.
Answer by DrLact: About HBF 386 usage in lactation
No information is available on the use of HBF 386 during breastfeeding. Most sources consider breastfeeding to be contraindicated during maternal antineoplastic drug therapy. The manufacturer recommends that breastfeeding be discontinued during HBF 386 therapy and for 14 days after the last dose.
Alternate Drugs
Bleomycin(Dangerous)
Doxorubicin(Dangerous)
Dactinomycin(Dangerous)
Alemtuzumab(Low Risk)
Vinblastine(Dangerous)
Etoposide(Dangerous)
Docetaxel(Dangerous)
Rituximab(Low Risk)
Pazopanib(Unsafe)
Bleomycin(Dangerous)
Doxorubicin(Dangerous)
Bevacizumab(Low Risk)
Vinorelbine(Dangerous)
Cyclophosphamide(Dangerous)
Dacarbazine(Dangerous)
Cisplatin(Unsafe)
Trastuzumab(Unsafe)
Busulfan(Dangerous)
Letrozole(Dangerous)
Imatinib(Unsafe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Cladribine(Dangerous)
Exemestane(Dangerous)
Azelaic Acid(Safe)
Dasatinib(Unsafe)
Dactinomycin(Dangerous)
Nilotinib(Unsafe)
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Ipilimumab(Unsafe)
Cetuximab(Unsafe)
Mitoxantrone(Dangerous)
Carboplatin(Dangerous)
Mercaptopurine(Safe)
Gemcitabine(Dangerous)
Paclitaxel(Dangerous)
Fluorouracil(Dangerous)
Nivolumab(Unsafe)
Hydroxyurea(Low Risk)
Dactinomycin(Dangerous)
Fusidic Acid(Safe)
Dactinomycin(Dangerous)